<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Approach to prenatal diagnosis of the lethal (life-limiting) skeletal dysplasias
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Approach to prenatal diagnosis of the lethal (life-limiting) skeletal dysplasias
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Approach to prenatal diagnosis of the lethal (life-limiting) skeletal dysplasias
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Phyllis Glanc, MD, FRCPC, FACR
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Chitayat, MD, FACMG, FCCMG, FRCPC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Deborah Levine, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Louise Wilkins-Haug, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Vanessa A Barss, MD, FACOG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 03, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H2348162">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Skeletal dysplasias (also called osteochondrodysplasia) are a large, heterogeneous group of conditions involving the formation and growth of bone and include osteodysplasia, chondrodysplasia, and dysostosis. Although more than 450 skeletal dysplasias have been identified, only a few are lethal in the prenatal/postnatal period. Typically, fetuses with lethal skeletal dysplasias have a reduction in bone length accompanied by a decrease in the bone growth trajectory. Assessment of fetal rib and lung growth are also critical in distinguishing lethal from nonlethal skeletal dysplasias.
        </p>
        <p>
         This topic will focus on the lethal skeletal dysplasias that present prenatally and will offer a systematic detailed approach to enable evaluation of lethality and help the practitioner determine a specific diagnosis. The majority of skeletal dysplasias will ultimately present postnatally either in the neonatal period or over time. Postnatal evaluation, clinical findings, and diagnosis of skeletal dysplasias are reviewed separately. (See
         <a class="medical medical_review" href="/z/d/html/13551.html" rel="external">
          "Skeletal dysplasias: Approach to evaluation"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">
          "Skeletal dysplasias: Specific disorders"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4098805115">
         <span class="h1">
          BACKGROUND
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Etiology
         </strong>
         – Skeletal dysplasias are primarily caused by genetic variants, but they may also be related to extrinsic causes, including maternal exposure to drugs (eg,
         <a class="drug drug_general" data-topicid="10095" href="/z/d/drug information/10095.html" rel="external">
          thalidomide
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ] and maternal diseases (eg, diabetes mellitus with poor glycemic control, autoimmune diseases) [
         <a href="#rid2">
          2,3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Classification system
         </strong>
         – A nosology and classification system categorizes genetic bone disorders into 461 different diseases classified into 42 major groups based on their clinical, radiographic, and/or molecular phenotype [
         <a href="#rid4">
          4
         </a>
         ]. Pathogenetic variants affecting 437 genes have been identified in 425 of the 461 (92 percent) disorders. (See
         <a class="medical medical_review" href="/z/d/html/13551.html" rel="external">
          "Skeletal dysplasias: Approach to evaluation", section on 'Classification of skeletal dysplasias'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence
         </strong>
         – Overall, skeletal dysplasias account for approximately 5 percent of genetic disorders identified in the newborn period [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The overall birth prevalence of skeletal dysplasias is estimated to be 2.4 to 4.5 per 10,000 births [
         <a href="#rid6">
          6
         </a>
         ]. The overall prevalence during pregnancy appears to be slightly higher at 7.5 per 10,000 ultrasound-screened pregnancies [
         <a href="#rid7">
          7
         </a>
         ]. Each individual skeletal dysplasia is very rare, given that there are 461 different skeletal dysplasias currently published [
         <a href="#rid1">
          1,4,8,9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         The prevalence of the lethal skeletal dysplasias ranges from 0.95 to 1.5 per 10,000 live births [
         <a href="#rid8">
          8-10
         </a>
         ]. The three most common lethal skeletal dysplasias are thanatophoric dysplasia (29 percent) [
         <a href="#rid11">
          11
         </a>
         ], osteogenesis imperfecta type 2 (14 percent), and achondrogenesis (9 percent) [
         <a href="#rid12">
          12
         </a>
         ], which account for 40 to 60 percent of all lethal skeletal dysplasias [
         <a href="#rid9">
          9,13-15
         </a>
         ]. Chondroectodermal dysplasia, campomelic dysplasia, and Jeune asphyxiating thoracic dysplasia are also among the more common lethal skeletal dysplasias, although it should be noted that this latter group is variably lethal depending on the severity of phenotypic expression [
         <a href="#rid16">
          16
         </a>
         ]. The percentages cited are from specific tertiary centers and reflect the rate of consanguinity and the specific ethnic background of the population served by the tertiary center.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prenatal identification
         </strong>
         – The fetal skeleton has a high level of intrinsic contrast, which permits early evaluation of the skeleton by ultrasound. Skeletal dysplasias begin to manifest in the early stages of fetal development. The lethal group typically has an earlier onset with more severe phenotypic features than the nonlethal group; thus, lethal skeletal dysplasias are potentially more amenable to prenatal diagnosis [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Perinatal mortality
         </strong>
         – Approximately 50 percent of skeletal dysplasias are lethal perinatally [
         <a href="#rid18">
          18
         </a>
         ]. The overall frequency of perinatal deaths due to skeletal dysplasias is approximately 9 per 1000 births, with 23 percent stillborn and an additional 32 percent who do not survive beyond the first week of life [
         <a href="#rid9">
          9,19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2348183">
         <span class="h1">
          OVERVIEW OF PRENATAL DIAGNOSIS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prenatal diagnostic accuracy is critical, as it will significantly affect parental counseling and decision-making regarding the pregnancy management as well as the patient's reproductive options, including preimplantation or prenatal genetic testing in future pregnancies.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prenatal diagnosis is based primarily upon fetal ultrasound findings, but magnetic resonance imaging (MRI), computed tomography (CT), radiography, and molecular analysis may be used to support the presumptive diagnosis. (See
         <a class="local">
          'Initial ultrasound evaluation'
         </a>
         below and
         <a class="local">
          'Role of specialized imaging techniques'
         </a>
         below and
         <a class="local">
          'Role of molecular diagnostic testing'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prenatal screening and diagnosis are primarily performed in the second trimester, but late-first-trimester fetal structural assessment is becoming more common with advances in transvaginal ultrasound imaging and the widespread use of first-trimester nuchal translucency evaluation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fetal skeletal dysplasias may be suspected because the femur is found to be short for gestational age or qualitative bony abnormalities are observed during a fetal anatomic survey. In some cases, the initial fetal ultrasound is performed because of a family history of skeletal dysplasia, although most cases have no family history of the disorder.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A comprehensive assessment of the fetal skeleton is necessary to determine which bones are affected and the type and severity of the abnormalities. Concurrently, a comprehensive evaluation of all fetal organ systems is performed. The composite findings may or may not point to a specific skeletal dysplasia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Over the past decade, the accuracy of prenatal ultrasound for diagnosis of skeletal dysplasia has improved significantly: 68 percent for correct prenatal diagnosis and 31 percent for partially correct diagnosis, with 0.07 percent false positives [
         <a href="#rid13">
          13,14,16,20-24
         </a>
         ]. Accurate prediction of lethality is considered to be extremely high (see
         <a class="local">
          'Predicting lethality'
         </a>
         below). A family history of consanguinity, a sibling or a parent affected with a skeletal dysplasia, or a prior affected fetus can help in making a specific diagnosis. However, the low incidence, phenotypic variability, overlapping features, and lack of family history in most cases make a specific diagnosis, and thus prognostic counseling, difficult.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Invasive procedures to obtain fetal DNA for a specific molecular analysis can confirm the diagnosis in some cases (see
         <a class="local">
          'Role of molecular diagnostic testing'
         </a>
         below). Despite the rare occurrence of any specific dysplasia, a combination of radiology, pathology, and molecular analysis can allow classification to a specific group in up to 99 percent of cases, using the Nosology and Classification of Genetic Skeletal Disorders [
         <a href="#rid6">
          6,25
         </a>
         ]. (See
         <a class="local">
          'Postnatal/post-termination evaluation'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         When a specific skeletal dysplasia cannot be identified, the immediate prenatal goal is to determine whether the dysplasia is lethal or nonlethal (see
         <a class="local">
          'Predicting lethality'
         </a>
         below). Diagnostic accuracy is critical, as the patient may choose to terminate the pregnancy or avoid cesarean delivery if the skeletal dysplasia is lethal or associated with high morbidity and quality of life that are unacceptable to the parents.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After birth, postnatal radiographs, autopsy (in lethal cases and/or terminated pregnancies), and molecular testing are crucial for making an accurate diagnosis [
         <a href="#rid20">
          20,26
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/13551.html" rel="external">
          "Skeletal dysplasias: Approach to evaluation"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2348190">
         <span class="h1">
          INITIAL ULTRASOUND EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H33599731">
         <span class="h2">
          Screening
         </span>
         <span class="headingEndMark">
          —
         </span>
         The ultrasound evaluation of the bones includes assessing their presence or absence, length, shape (curvature), and whether any fractures are present. These features can be visualized well at ≥14 weeks of gestation, as much of the skeleton begins to ossify early in development: the clavicle, mandible, ileum, scapula, and long bones ossify by 12 weeks of gestation and the metacarpals and metatarsals are ossified by 12 to 16 weeks [
         <a href="#rid27">
          27
         </a>
         ]. However, the talus and calcaneus ossify at weeks 22 to 24, epiphyseal ossification centers are seen on radiographs at approximately 20 weeks of gestation, and the carpal bones ossify after birth.
        </p>
        <p>
         International Society of Ultrasound in Obstetrics &amp; Gynecology (ISUOG) practice guidelines state that femur length (FL) should be measured on ultrasound examinations performed at ≥14 weeks [
         <a href="#rid28">
          28
         </a>
         ]. The femur is generally the only long bone routinely measured at the second-trimester ultrasound evaluation, although many scanning guidelines recommend the systematic documentation of the presence and symmetry of all extremities.
        </p>
        <p>
         The FL is imaged such that both ends of the ossified metaphysis are visible, and then the longest length of the femur diaphysis is measured  (
         <a class="graphic graphic_diagnosticimage graphicRef50944" href="/z/d/graphic/50944.html" rel="external">
          image 1
         </a>
         ). Several longitudinal measurements should be obtained, and the longest is recorded. There is a trend to call this measurement a femur diaphysis length (FDL) rather than a FL in order to more accurately reflect the actual measurement obtained.
        </p>
        <p class="headingAnchor" id="H3630569805">
         <span class="h2">
          Definition of short femur
         </span>
         <span class="headingEndMark">
          —
         </span>
         A short femur is typically defined as below the 5
         <sup>
          th
         </sup>
         percentile for gestational age, or less commonly below two standard deviations (SD) from the mean for the gestational age.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a prospective Danish population study, the 5
         <sup>
          th
         </sup>
         percentile corresponded to the mean minus 1.645 SD, leading the authors to suggest that a cutoff value closer to -2 SD instead of the 5
         <sup>
          th
         </sup>
         percentile should be considered to minimize overdiagnosis [
         <a href="#rid29">
          29
         </a>
         ]. In this study, an isolated short FL at the second-trimester anatomic scan was associated with a higher risk of chromosomal anomalies, in particular trisomy 21, and a higher risk for delivery of a small for gestational age infant and early preterm birth.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In another study of 27 fetuses with shortened femurs, a markedly short FL (≥5 mm below the -2 SD line [equivalent to &gt;-4.3 SD]) was associated with a high likelihood of a skeletal dysplasia, whereas a mildly shortened femur (within 4 mm of the -2 SD line [between -2 and -4 SD below the mean]) in combination with normal interval growth was unlikely to be associated with skeletal dysplasia [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H478122598">
         <span class="h2">
          Evaluation of the fetus with a mildly shortened femur
         </span>
         <span class="headingEndMark">
          —
         </span>
         The differential diagnosis for a mildly shortened FL includes normal variation, constitutional short limb, a false-positive measurement, fetal growth restriction (FGR) [
         <a href="#rid31">
          31
         </a>
         ], and aneuploidy (primarily trisomy 21). The following key points help in differential diagnosis when a short femur is detected on ultrasound:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The majority of isolated mildly short femurs represent normal variation or constitutional short stature, and has been termed "constitutional short femur." Over time, children with constitutional short stature will demonstrate normal interval growth of the long bones, but along a line below the normal centiles.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         As many as 13 percent of isolated mildly short femurs diagnosed at 18 to 24 weeks are reclassified as normal on follow-up [
         <a href="#rid32">
          32
         </a>
         ]. This suggests the original value was a measurement error rather than an interim catch up growth spurt.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Parental ethnicity impacts height and should be considered in interpretation of FL percentile. Mean FL is shorter in Asian populations compared with White populations and shorter in White populations compared with Black populations [
         <a href="#rid33">
          33,34
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The possibility of aneuploidy, in particular trisomy 21, should be considered as a mildly short femur is a soft marker of fetal aneuploidy, although the predictive value is low when this is an isolated finding and the patient is otherwise at low risk for fetal aneuploidy. The high detection rate for trisomy 21, using noninvasive prenatal screening (NIPS) by analyzing cell-free DNA, should be offered to rule out this possibility when amniocentesis is declined. (See
         <a class="medical medical_review" href="/z/d/html/458.html" rel="external">
          "Prenatal screening for common aneuploidies using cell-free DNA"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/447.html" rel="external">
          "Sonographic findings associated with fetal aneuploidy", section on 'Slightly short long bones'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The possibility of FGR should be considered. The diagnosis of FGR is supported by other sonographic evidence of growth restriction (eg, small abdominal circumference, abnormal placental morphology, abnormal Doppler parameters) and low pregnancy-associated plasma protein-A (PAPP-A) and placental growth factor (PlGF). An isolated short femur may be the presenting sign of FGR, but over time, other measurements, such as abdominal circumference and sometimes the head circumference, will also begin to drop below the normal growth curves for gestational age. (See
         <a class="medical medical_review" href="/z/d/html/6752.html" rel="external">
          "Fetal growth restriction: Screening and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Further sonographic evaluation of the fetus and serial examinations can help point to the correct diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         All long bones should be measured. The combination of a mildly short femur and mildly short humerus can be related to trisomy 21, FGR, or skeletal dysplasia [
         <a href="#rid31">
          31,35
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         If interim growth over three to four weeks is normal, and along the same growth curve, a short-limb skeletal dysplasia is unlikely. If FL over this interval falls further from the mean, skeletal dysplasia or severe FGR becomes more likely [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Findings most predictive of skeletal dysplasia include:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         FL more than 5 mm below the -2 SD value for gestational age (which is approximately the equivalent of more than 4 SD below the mean at the time of the fetal anatomic survey between 18 and 22 weeks) [
         <a href="#rid30">
          30
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Femur to foot length ratio &lt;0.9 [
         <a href="#rid36">
          36
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         FL to abdominal circumference ratio &lt;0.16 [
         <a href="#rid22">
          22,37
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33599767">
         <span class="h1">
          ESTABLISHING A DIAGNOSIS
         </span>
        </p>
        <p class="headingAnchor" id="H1607303178">
         <span class="h2">
          Refer to an expert
         </span>
         <span class="headingEndMark">
          —
         </span>
         When a short femur is identified in a fetus, we recommend referral to a center with expertise in skeletal dysplasias to perform a detailed ultrasound examination, determine the etiology of the short femur, make a specific diagnosis (if possible), and provide counseling [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4265087087">
         <span class="h2">
          Components of a comprehensive ultrasound evaluation for skeletal dysplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         The components of detailed ultrasound assessment are listed in the table  (
         <a class="graphic graphic_table graphicRef63933" href="/z/d/graphic/63933.html" rel="external">
          table 1
         </a>
         ) and discussed below.
        </p>
        <p class="headingAnchor" id="H2348206">
         <span class="h3">
          Pattern of limb shortening
         </span>
         <span class="headingEndMark">
          —
         </span>
         All long bones (ie, each femur, humerus, radius, ulna, tibia, and fibula) should be measured to determine the relative shortening against normative values. There are four main patterns of limb shortening:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rhizomelia, shortening of the proximal segment (femur and humerus)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Mesomelia, shortening of the middle segment (radius, ulna, tibia, and fibula)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Acromelia, shortening of the distal segment (hands and feet)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Micromelia, shortening of all parts of the limb. Micromelia is further subdivided into mild, mild and bowed, or severe  (
         <a class="graphic graphic_diagnosticimage graphicRef54680" href="/z/d/graphic/54680.html" rel="external">
          image 2
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         The majority of prenatally diagnosed skeletal dysplasias are associated with severe micromelia, but the foot length typically is relatively maintained. The femur to foot length ratio is normally 1.0 throughout the pregnancy; thus, a ratio &lt;1.0 is useful to instigate a systematic evaluation in order to distinguish skeletal dysplasia from other causes of short femur, such as fetal growth restriction (FGR) or aneuploidy [
         <a href="#rid36">
          36
         </a>
         ]. When the ratio falls below 0.9, the likelihood of a skeletal dysplasia is increased relative to these other diagnoses.
        </p>
        <p class="headingAnchor" id="H1381430891">
         <span class="h3">
          Timing of onset of limb shortening
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the earlier the onset of documented limb shortening, the graver the prognosis. The most common nonlethal skeletal dysplasia is the heterozygous form of achondroplasia and demonstrates a later onset, where limb length is typically preserved until around 22 weeks of gestation with a subsequent progressive drop below the normal percentiles with a rhizomelic pattern.
        </p>
        <p class="headingAnchor" id="H2348213">
         <span class="h3">
          Qualitative assessment of long bones
         </span>
         <span class="headingEndMark">
          —
         </span>
         Assessment of long bones includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Shape (bowing, angulation, contour, metaphyseal flaring)
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Bowing/bending/angulation of the femurs is a finding in most skeletal dysplasias, but the four most common are campomelic dysplasia, thanatophoric dysplasia (TD), achondroplasia, and osteogenesis imperfecta. Conditions that are associated with isolated bowed femurs include Stuve-Wiedemann [
         <a href="#rid39">
          39
         </a>
         ] and Schwartz-Jampel [
         <a href="#rid40">
          40
         </a>
         ] syndromes, amongst others.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Metaphyseal flaring is associated with Kniest syndrome.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Mineralization and presence of fractures
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Decreased mineralization of the long bones is most reliably diagnosed by the presence of fractures; decreased or absent acoustic shadowing is a less reliable marker. Bone fractures may appear as angulations or interruptions in the bone contour or as thick, wrinkled contours corresponding to repetitive cycles of fracture and callus formation. These findings are common in osteogenesis imperfecta, achondrogenesis, and hypophosphatasia congenita.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Absence of individual long bones
         </strong>
         (fibula, tibia, radius)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Joint deformities
         </strong>
         . Multiple joint contractures in association with kyphoscoliosis and micromelia are typical of diastrophic dysplasia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Premature ossification of the epiphysis
         </strong>
         in association with multiple ossification centers ("stippled epiphysis") is characteristic of chondrodysplasia punctata but may also be associated with
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         embryopathy and maternal systemic lupus erythematosus and other autoimmune diseases [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33600189">
         <span class="h3">
          Qualitative assessment of other bones
         </span>
         <span class="headingEndMark">
          —
         </span>
         Specific dysmorphic features of other bones (eg, clavicular or scapular hypoplasia; platyspondyly [flattened vertebral bodies]) can be helpful to further define a specific skeletal dysplasia.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Spine
         </strong>
         — The spine is assessed for segmentation anomalies, kyphoscoliosis, platyspondyly, demineralization, myelodysplasia, and caudal regression. Although platyspondyly is the most common spine abnormality, it may be difficult to diagnose on prenatal ultrasound [
         <a href="#rid41">
          41
         </a>
         ]. Severe platyspondyly is present in TD and lethal variants of osteogenesis imperfecta. Milder degrees of platyspondyly may be present in conditions such as fibrochondrogenesis, de la Chapelle dysplasia, and Kniest syndrome, amongst others. Vertebral disorganization with secondary kyphoscoliosis may be associated with syndromes such as dyssegmental dysplasia and costovertebral dysplasia (Jarcho-Levin syndrome) [
         <a href="#rid42">
          42
         </a>
         ]. Under-ossification of the spine is seen in conditions such as atelosteogenesis, achondrogenesis, and hypophosphatasia. Disproportionate short-trunk skeletal dysplasia with absent limb length shortening can occur in spondyloepiphyseal dysplasia or secondary to lysosomal storage disorders with bone involvement.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Hands and feet
         </strong>
         — Common deformities of the hands and feet include clubfoot, rocker bottom foot, clubhand, short fingers (brachydactyly), or an abnormal number of digits. The position of the thumbs and toes can provide a clue to the diagnosis; a hitchhiker thumb or abducted thumb/first toe is present in diastrophic dwarfism. Polydactyly (extra digits) suggests a group of conditions known as short-rib polydactyly syndromes (eg, Ellis-van Creveld syndrome, Jeune asphyxiating thoracic dystrophy, Saldino-Noonan, etc) and some chromosomal abnormalities. Joint contractures suggest skeletal dysplasias associated with arthrogryposis multiplex congenita and fetal akinesia syndromes. Syndactyly is associated with Apert syndrome, and oligodactyly is associated with De Lange and Roberts syndromes.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Calvarium
         </strong>
         — In most skeletal dysplasias with prenatal onset, the long bones are disproportionately short, and the calvarium is normal or large. The cranium is also evaluated for macrocephaly or microcephaly, frontal bossing, cloverleaf skull deformity, and underlying brain abnormalities. Of particular note, temporal lobe dysplasia is associated with TD, achondroplasia, and hypochondroplasia associated with variants in the fibroblast growth factor receptor 3 (
         <em>
          FGFR3
         </em>
         ) gene group of genetic disorders [
         <a href="#rid43">
          43-45
         </a>
         ]. An abnormal cranial contour and cloverleaf skull may indicate premature fusion of the sutures (craniosynostosis). Common craniosynostosis syndromes, such as Apert, Crouzon, Carpenter, Muenke, and Pfeiffer syndromes, manifest with craniosynostosis in association with limb anomalies such as syndactyly ("mitten hands"), abducted thumbs, and polydactyly. Macrocephaly is associated with TD, achondroplasia, and achondrogenesis but can also be constitutional. (See
         <a class="medical medical_review" href="/z/d/html/2910.html" rel="external">
          "Overview of craniosynostosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2942.html" rel="external">
          "Craniosynostosis syndromes"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Decreased mineralization of the calvarium may present with a range of sonographic findings from enlarged fontanelles to extreme demineralization where the midline falx appears more echogenic than the calvarium itself. Abnormal compressibility of the cranial vault with normal transducer pressure is considered a reliable finding in cranial vault demineralization. These findings may be associated with osteogenesis imperfecta type 2, achondrogenesis, or hypophosphatasia congenita. Absent calvarial ossification/very large fontanelles can also be seen in cleidocranial dysplasia and renal tubular dysgenesis, as well as in prenatal exposure to angiotensin converting enzyme inhibitors [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Face
         </strong>
         — Common facial abnormalities include midface hypoplasia, saddle nose deformity, hypertelorism, cleft lip and palate, frontal bossing, micrognathia (mandibular hypoplasia), and retrognathia (abnormal posterior positioning of the mandible or maxilla)  (
         <a class="graphic graphic_diagnosticimage graphicRef65436" href="/z/d/graphic/65436.html" rel="external">
          image 3
         </a>
         ). The bi-orbital diameter should be measured to assess for hypotelorism or hypertelorism. TD is characterized by the combination of midface hypoplasia, saddle nose deformity, and high forehead and frontal bossing.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Osteogenesis imperfecta type 2, the lethal variant, is usually caused by an autosomal dominant de novo genetic variant in
         <em>
          COL1A1
         </em>
         or
         <em>
          COL1A2
         </em>
         (coding for the type I collagen) and typically presents with facial dysmorphism including a triangular face with prominent eyes and retrognathia/micrognathia. Variants in the
         <em>
          COL2A1
         </em>
         gene, coding for type II collagen and associated with a variety of conditions including Kniest syndrome and Stickler syndrome type 1, also present with micrognathia/retrognathia but usually with cleft palate (Robin sequence) and prominent eyes with severe myopia and retinal detachment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Ribs
         </strong>
         — Ribs are assessed for abnormal appearance or number. Short ribs, encircling less than 70 percent of the thorax, are associated with lethal skeletal dysplasias. This will result in a narrow anteroposterior diameter of the thorax, a flared appearance to the lower thorax, and a reduced thoracic circumference. Rib fractures may result in angulation or, when numerous, in a beaded appearance.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Associated syndromes with abnormal appearance/number of ribs include costovertebral dysplasia (Jarcho-Levin syndrome), Poland anomaly, VACTERL association (vertebral abnormalities, anal atresia, cardiac abnormalities, tracheoesophageal fistula, renal abnormalities, limb abnormalities), campomelic dysplasia, and chromosome abnormalities.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Scapula
         </strong>
         — Hypoplastic or absent scapula is commonly noted in campomelic dysplasia but may also occur in Cousin syndrome, Kosenow syndrome, and Antley-Bixler syndrome [
         <a href="#rid47">
          47
         </a>
         ]. Within the platyspondylic lethal skeletal dysplasias, the presence of two inferior spikes suggests the Luton variety. A review by Mortier et al [
         <a href="#rid48">
          48
         </a>
         ] includes an excellent schematic demonstrating the various scapular anomalies and the associated syndromes  (
         <a class="graphic graphic_figure graphicRef118382" href="/z/d/graphic/118382.html" rel="external">
          figure 1
         </a>
         ) [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pelvic bones
         </strong>
         — Although important to evaluate, the pelvic bones are difficult to assess on conventional two-dimensional (2D) ultrasound and additional three-dimensional (3D) techniques may be required to appreciate the shape of the iliac bones and the sacrosciatic notches.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Achondrogenesis, a relatively common lethal musculoskeletal dysplasia presents with multiple abnormalities including abnormal decreased mineralization in the ischium and pubic bones. "Squared" iliac bones are features of both TD and achondroplasia.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H33600291">
         <span class="h3">
          Nonskeletal anatomic survey
         </span>
         <span class="headingEndMark">
          —
         </span>
         A detailed evaluation of the cardiovascular, genitourinary, gastrointestinal, and central nervous system should be done concurrently with the skeletal evaluation. The composite findings may or may not point to a specific skeletal dysplasia.
        </p>
        <p>
         In many fetal skeletal dysplasias, the skin and subcutaneous layers continue to grow at a faster rate than the long bones, resulting in relatively thickened skin folds, which may be mistaken for skin edema. Polyhydramnios is common and may be related to a combination of factors, including esophageal compression (by a small chest), micrognathia, associated gastrointestinal abnormalities, and hypotonia with decreased swallowing.
        </p>
        <p class="headingAnchor" id="H2348269">
         <span class="h2">
          Role of specialized imaging techniques
         </span>
        </p>
        <p class="headingAnchor" id="H2348276">
         <span class="h3">
          Three-dimensional ultrasound
         </span>
         <span class="headingEndMark">
          —
         </span>
         3D ultrasound is becoming an increasingly useful complement to 2D ultrasound in diagnosis of skeletal dysplasia and pulmonary hypoplasia [
         <a href="#rid49">
          49-52
         </a>
         ]. However, studies defining the role of 3D ultrasound as compared with 2D ultrasound in skeletal dysplasias are limited [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
         High contrast structures such as the fetal skeleton are especially amenable to 3D ultrasound rendering software. Coronal multiplanar reformation (MPR; ie, the process of using the data from axial computed tomography [CT] images to create nonaxial 2D images) appears to be particularly helpful in defining segmentation vertebral anomalies or helping to define the type of scapular anomaly. Surface rendering capabilities are particularly useful to visualize subtle facial dysmorphism, such as low set or deformed ears, micrognathia, flattening of the facial profile associated with midface hypoplasia, cranial distortion due to craniostenosis, or assessing hand/foot abnormalities [
         <a href="#rid49">
          49
         </a>
         ]. However, there are insufficient published data to gauge the diagnostic performance of this modality. (See
         <a class="local">
          'Computed tomography'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H33600740">
         <span class="h3">
          Magnetic resonance imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         After 20 weeks of gestation, magnetic resonance imaging (MRI) may play a complementary role to ultrasound because it can identify and better define some abnormalities, particularly of the brain. There are no known deleterious effects of fetal unenhanced MRI on the developing fetus. Postnatally, MRI can be useful in the context of "virtual autopsy" in families who have declined autopsy [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4791.html" rel="external">
          "Diagnostic imaging in pregnant and lactating patients", section on 'Magnetic resonance imaging'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2348290">
         <span class="h3">
          Computed tomography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prenatal low-dose 3D-CT can provide detailed images of bone morphology with complete 3D rendering of the fetal skeleton with fetal radiation exposure in the 3 mGy range when technical factors are optimized to minimize radiation dose [
         <a href="#rid49">
          49,55,56
         </a>
         ]. In 2009, the International Commission on Radiological Protection concluded that in utero dose exposures less than 100 mGy is below the threshold for induction of malformations and that the lifetime risk of childhood cancer would be similar to that following irradiation in early childhood [
         <a href="#rid57">
          57
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4791.html" rel="external">
          "Diagnostic imaging in pregnant and lactating patients", section on 'Fetal risks'
         </a>
         .)
        </p>
        <p>
         This modality should be considered if dilation and extraction is planned for pregnancy termination since it is likely to result in fetal fragmentation. It should also be considered after 20 weeks of gestation in the diagnostic evaluation of some cases of suspected skeletal dysplasia when the diagnosis remains uncertain after other imaging modalities have been performed and additional information may affect pregnancy management.
        </p>
        <p>
         In one study, the diagnostic utility of low-dose fetal CT was similar to a postnatal radiographic skeletal survey and, in 59 percent of their cases, the findings changed the ultrasound-provided diagnosis to the correct one, thus permitting more accurate management and counseling in the prenatal period [
         <a href="#rid58">
          58
         </a>
         ]. In another study, low-dose fetal CT revealed additional findings in up to 81 percent of cases, which sometimes led to a more specific diagnosis [
         <a href="#rid59">
          59
         </a>
         ]. It should be noted that studies have not compared 3D-CT with state-of-the-art 3D ultrasound skeletal bony rendering; thus, its potential benefits compared with contemporary 3D-ultrasound are unclear and evolving.
        </p>
        <p>
         Postnatally, 3D-CT can be useful in the context of "virtual autopsy" in families who have declined autopsy. Postnatal 2D CT is not performed routinely, but sometimes used in specific clinical settings. (See
         <a class="medical medical_review" href="/z/d/html/13551.html" rel="external">
          "Skeletal dysplasias: Approach to evaluation", section on 'Imaging'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3379490144">
         <span class="h3">
          Radiography
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prenatal radiography has a limited role in prenatal diagnosis of skeletal disorders because the superimposition of fetal and maternal bones makes interpretation difficult.
        </p>
        <p>
         Postnatal radiography (skeletal survey), however, plays a critical role in defining the characteristic skeletal features present in many skeletal dysplasias. (See
         <a class="medical medical_review" href="/z/d/html/13551.html" rel="external">
          "Skeletal dysplasias: Approach to evaluation", section on 'Imaging'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H33600788">
         <span class="h2">
          Role of molecular diagnostic testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         The molecular diagnosis of a specific skeletal dysplasia is useful in predicting the prognosis [
         <a href="#rid60">
          60,61
         </a>
         ]. Fetal DNA for molecular diagnostic testing can be performed via chorionic villus sampling (performed transcervically at 11 to 14 weeks of gestation or transabdominally after 11 weeks of gestation) or amniocentesis (performed at ≥15 weeks of gestation). (See
         <a class="medical medical_review" href="/z/d/html/449.html" rel="external">
          "Chorionic villus sampling"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5390.html" rel="external">
          "Diagnostic amniocentesis"
         </a>
         .) Circulating cell-free DNA in maternal blood has been used to identify single gene disorders such as achondroplasia and TD, thus providing a noninvasive tool for supporting the sonographic diagnosis [
         <a href="#rid62">
          62
         </a>
         ]. However, as in all cases with major fetal abnormalities identified on ultrasound, cell-free DNA analysis for single gene disorders has limited availability and generally not recommended since a negative result can provide false assurance.
        </p>
        <p>
         The role of molecular studies for diagnosis of a specific skeletal dysplasia in an ongoing pregnancy with no personal or family history is controversial since the time necessary for DNA analysis can be lengthy and a negative result or failure to identify a specific genetic variant does not change the clinical implications derived from the ultrasound findings. Furthermore, variants in the same gene can cause different forms of skeletal dysplasia and variants in different genes can cause similar skeletal abnormalities [
         <a href="#rid63">
          63
         </a>
         ]. Nevertheless, molecular analysis (gene panels, exome sequencing [ES], genome sequencing [GS]) can be an important diagnostic tool in cases of suspected skeletal dysplasia when there is no family history of a specific condition and when no specific diagnosis can be made based on fetal imaging [
         <a href="#rid64">
          64
         </a>
         ]. Since detailed fetal ultrasound has a high detection rate for lethal skeletal dysplasia, molecular analysis in these cases is mainly needed for prenatal and preimplantation genetic testing for future pregnancies rather than for prognostication in the affected pregnancy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prior affected fetus
         </strong>
         – For parents with a prior affected fetus due to a new dominant disorder, there is no consensus whether molecular diagnosis should be performed for a relatively low risk of germline mosaicism. In most of these cases, the risk for a miscarriage associated with the prenatal invasive procedures is probably higher than the risk that the fetus will be affected [
         <a href="#rid65">
          65
         </a>
         ]; furthermore, fetal ultrasound is reliable in making a relatively early diagnosis. Likewise, the role of molecular diagnosis for a skeletal dysplasia in an ongoing pregnancy is controversial since the time necessary for DNA analysis can be lengthy and a negative result or failure to identify a specific condition does not change the clinical implications derived from the ultrasound findings.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Parent is affected or a known carrier
         </strong>
         – Fetal DNA is analyzed for specific variants when the fetus is known to be at risk for having skeletal dysplasia because of an affected parent (in autosomal dominant conditions), a carrier mother (for an X-linked condition), or parents identified as being carriers of an autosomal recessive skeletal dysplasia (due to a personal or family history of an affected child/fetus). Genetic variants have been identified for approximately 70 percent of skeletal dysplasias [
         <a href="#rid18">
          18,66
         </a>
         ] and can be used to provide early prenatal diagnosis (before diagnostic findings are seen on ultrasound), preimplantation diagnosis in at-risk families, or to confirm the presumptive diagnosis on imaging performed later in pregnancy. A microarray analysis is usually performed at the same time and can provide diagnostic information. (See
         <a class="medical medical_review" href="/z/d/html/16683.html" rel="external">
          "Prenatal diagnosis of chromosomal imbalance: Chromosomal microarray"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When both parents are affected with the same or different autosomal dominant skeletal disorders, the fetus is at high risk of lethality because of homozygosity or compound heterozygosity for the same condition, or heterozygosity for two dominant conditions (double heterozygote) [
         <a href="#rid67">
          67
         </a>
         ]. For example, when both parents are affected with achondroplasia, the most common skeletal dysplasia, the likelihood of having a fetus with homozygote or compound heterozygote variant in the
         <em>
          FGFR3
         </em>
         gene associated with achondroplasia, and thus with the lethal form, is 25 percent, while the risk for having a fetus with achondroplasia is 50 percent. In such cases, molecular diagnosis is useful to distinguish between a fetal heterozygote, homozygote, and compound heterozygote [
         <a href="#rid68">
          68
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         When one parent has an autosomal recessive skeletal dysplasia, the risk of an affected fetus is relatively low and the appropriateness of molecular diagnosis is less clear.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H544667520">
         <span class="h1">
          PREGNANCY MANAGEMENT
         </span>
        </p>
        <p class="headingAnchor" id="H298115852">
         <span class="h2">
          Counseling
         </span>
         <span class="headingEndMark">
          —
         </span>
         The finding of a skeletal dysplasia and the subsequent communication of this news are difficult tasks, which require empathy and support. Referral to a clinician with expertise in clinical genetics to discuss possible phenotypes/genotypes in offspring, options for prenatal diagnosis, prognosis, and reproductive options, can be very helpful.
        </p>
        <p>
         When ultrasound and any additional diagnostic evaluations lead to the diagnosis of a specific skeletal dysplasia, parents can be given prognostic information (see
         <a class="local">
          'Predicting lethality'
         </a>
         below). However, for many parents, the diagnosis of a skeletal dysplasia is sufficient for making a decision regarding pregnancy management. In many cases, the exact diagnosis is not known, but the prognosis is evident based on the ultrasound findings and/or the findings on molecular analysis.
        </p>
        <p>
         The fetal findings and the implications should be explained in language that is simple to understand so that the parents can make an informed decision regarding the management of the pregnancy and possible delivery and postnatal care. Cultural differences need to be respected and taken into consideration during the counseling process.
        </p>
        <p>
         Pregnancy options include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Obtain further information prior to making a decision, with repeated fetal ultrasound, fetal echocardiography, fetal magnetic resonance imaging (MRI), and further counseling by specialists from other disciplines, such as medical geneticists, neonatologists, orthopedic surgeons, palliative treatment groups, social workers, organizations/groups of other affected families, and the parents' religious or community sources of support.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Results from amniocentesis for DNA analysis for a specific condition or exome sequencing (ES)/genome sequencing (GS) when no specific condition is suspected may aid in decision making. For fetal skeletal anomalies overall, exome sequencing increased diagnostic yield by about 50 percent over microarray in a systematic review (pooled increased diagnostic yield: 53 percent, 95% CI 42-63 percent) [
         <a href="#rid69">
          69
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continue the pregnancy with repeated fetal ultrasound examinations and counseling by specialists from other disciplines as appropriate regarding the management of delivery and postnatal care. The route of delivery, especially in cases with fetal macrocrania (which may preclude vaginal delivery), and the extent of postnatal treatment should be discussed, and the poor prognosis should be kept in mind.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Pregnancy termination.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3133273410">
         <span class="h2">
          Predicting lethality
         </span>
        </p>
        <p class="headingAnchor" id="H2251382600">
         <span class="h3">
          Overview
         </span>
         <span class="headingEndMark">
          —
         </span>
         One of the most important determinations that needs to be made prenatally is whether the condition is lethal: resulting in intrauterine death or in neonatal death (from respiratory failure caused by pulmonary hypoplasia  (
         <a class="graphic graphic_diagnosticimage graphicRef59648" href="/z/d/graphic/59648.html" rel="external">
          image 4
         </a>
         )). After a lethal prognosis is established, evaluation of key sonographic features is performed to attempt to determine a specific diagnosis.
        </p>
        <p>
         Prediction of lethality on prenatal ultrasound has been reported to be highly accurate, ranging from 81 to more than 99 percent [
         <a href="#rid13">
          13,14,16,70
         </a>
         ]. In the largest prospective study using a standardized ultrasound approach to the evaluation of these disorders, lethality was accurately predicted in 96.8 percent of 500 cases in the International Skeletal Dysplasia Registry [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
         The literature indicates that death occurs in this group before or during the neonatal period, typically due to respiratory failure. However, in one study of a cohort of 38 infants with typically lethal skeletal dysplasias, including thanatophoric dysplasia, achondrogenesis, and osteogenesis imperfecta type IIA, the survival rate was 50 percent in the neonatal period and 28.9 percent at one year of life [
         <a href="#rid71">
          71
         </a>
         ]. This group of infants required aggressive medical intervention, including intubation in 78.9 percent, mechanical ventilation in 92.1 percent, and tracheostomy placement in 23.7 percent. Because of such data, it has been suggested that a diagnosis of lethality should be replaced by the term "lethal or life-limiting" to more fully encompass the potential postnatal clinical course with aggressive medical support [
         <a href="#rid72">
          72
         </a>
         ]. Contemporary data should be considered when counseling parents about the most common of the so called "lethal" skeletal dysplasias, acknowledging some limitations of the diagnosis of "lethality." As part of this counseling, the clinician should discuss with parents whether they want heroic measures to treat the newborn and their decision should be respected.
        </p>
        <p class="headingAnchor" id="H3551863937">
         <span class="h3">
          First trimester prognostic findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the earlier in gestation a skeletal dysplasia is detected, the worse the prognosis. The majority of cases identified in the first trimester represent lethal skeletal dysplasias [
         <a href="#rid17">
          17
         </a>
         ]. In the first trimester, the combination of increased nuchal translucency, short femurs, abnormal skull shape, lack of or low degree of mineralization, and small chest is highly predictive of a lethal skeletal dysplasia [
         <a href="#rid17">
          17,73
         </a>
         ]. When increased nuchal translucency is associated with skeletal dysplasia, approximately 85 percent of cases are lethal skeletal dysplasias [
         <a href="#rid17">
          17,73
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2039921050">
         <span class="h3">
          Second and third trimester prognostic findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is important to use multiple sonographic parameters to obtain the most accurate diagnosis of lethality (caused by the pulmonary hypoplasia associated with the small chest circumference) [
         <a href="#rid74">
          74
         </a>
         ]. Findings suggestive of pulmonary hypoplasia include  (
         <a class="graphic graphic_diagnosticimage graphicRef59648" href="/z/d/graphic/59648.html" rel="external">
          image 4
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thoracic circumference &lt;5
         <sup>
          th
         </sup>
         percentile, measured at the level of the four-chamber heart view
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thoracic to abdominal circumference ratio &lt;0.6 [
         <a href="#rid1">
          1,24
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Short thoracic length (from the neck to the diaphragm compared with nomograms)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Ribs that encircle less than 70 percent of the thoracic circumference at the level of the four-chamber cardiac view [
         <a href="#rid75">
          75
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Markedly narrowed anteroposterior diameter (sagittal view)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Concave or bell-shaped contour of the thorax (coronal view)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Heart to chest circumference ratio &gt;50 percent [
         <a href="#rid24">
          24
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Femur length (FL) to abdominal circumference ratio &lt;0.16; this ratio is even more predictive when associated with polyhydramnios [
         <a href="#rid1">
          1,24,37
         </a>
         ]
        </p>
        <p>
        </p>
        <p>
         A comparative study of eight different methods for the prediction of fetal lung hypoplasia determined that the lung volumes and the thoracic circumference to abdominal circumference ratios performed best [
         <a href="#rid76">
          76
         </a>
         ]; however, the majority of these studies were performed in the congenital diaphragmatic hernia population and may not be generalizable to this population [
         <a href="#rid77">
          77,78
         </a>
         ].
        </p>
        <p>
         Although several studies have described normal fetal lung volumes, there are limited data on lung volumes measured by ultrasound and magnetic resonance imaging (MRI) in fetuses with musculoskeletal disorders [
         <a href="#rid79">
          79
         </a>
         ]. One study showed the feasibility of three-dimensional ultrasound for measuring lung volumes in fetuses with skeletal dysplasia and found that it could accurately predict lethal pulmonary hypoplasia in these cases [
         <a href="#rid80">
          80
         </a>
         ], but larger studies are needed to confirm these results. It should be noted that measurements after 32 weeks were not performed due to technical limitations.
        </p>
        <p>
         Another study of a cohort of 23 patients with skeletal dysplasia reported that an observed/expected total fetal lung volume less than 47.9 percent on MRI was a predictor of a lethal skeletal dysplasia [
         <a href="#rid79">
          79
         </a>
         ]. This value is larger than that for lethal pulmonary hypoplasia in congenital diaphragmatic hernia, thus reinforcing the concept that larger studies need to be performed in the skeletal dysplasia population since results in the congenital diaphragmatic hernia population may not be generalizable to this population [
         <a href="#rid76">
          76-78
         </a>
         ]. Several reviews have demonstrated high variability in lung volume nomograms in different studies due to differing methodologies [
         <a href="#rid81">
          81-83
         </a>
         ]. This suggests MRI could be reserved for borderline cases of pulmonary hypoplasia and difficult diagnostic scenarios.
        </p>
        <p class="headingAnchor" id="H1156345454">
         <span class="h2">
          Postnatal/post-termination evaluation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Despite the rare occurrence of individual skeletal dysplasias, assessment of radiographic findings, molecular analysis, and pathology specimens enables postnatal assignment to a specific group within the 2010 and 2015 Nosology and Classification of Genetic Skeletal Disorders system in up to 99 percent of cases [
         <a href="#rid6">
          6,25,66
         </a>
         ].
        </p>
        <p>
         Fetal autopsy should be offered to identify the etiology of the skeletal dysplasia, especially if the diagnosis is uncertain or the results will affect future reproductive plans [
         <a href="#rid84">
          84
         </a>
         ]. For example, if there is an increased risk of recurrence, some parents may choose to have preimplantation genetic testing, egg/sperm or embryo donation, early prenatal diagnosis, or avoid subsequent pregnancy.
        </p>
        <p>
         It is preferable for the autopsy to be performed by a perinatal pathologist. If the parents decline a full postmortem evaluation, then a minimally invasive evaluation including external evaluation and imaging as well as DNA/fibroblasts/tissue banking may be of value.
        </p>
        <p>
         With parental consent, external and internal examinations are performed, and skeletal radiographs and photographs are taken. Histopathologic examination of bones, relevant tissue, and the placenta should be performed. The femur is the most useful bone for examination, as it offers bone and cartilaginous tissue in addition to two large growth plates. Bone and cartilage may be kept deeply frozen for later studies. Tissue should be referred for DNA extraction and banking, as well as fibroblast banking for further studies, including microarray analysis, genetic variant analysis for a specific gene disorder when a specific diagnosis is suspected, as well as gene panel and WES/WGS when no specific diagnosis is suspected [
         <a href="#rid85">
          85
         </a>
         ]. If ES is used, parental DNA should also be obtained to improve the diagnostic yield. (See
         <a class="medical medical_review" href="/z/d/html/104101.html" rel="external">
          "Prenatal genetic evaluation of the fetus with anomalies or soft markers", section on 'Advanced testing options'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1617642895">
         <span class="h2">
          Resources
         </span>
         <span class="headingEndMark">
          —
         </span>
         When local expertise is unavailable and/or the diagnosis cannot be determined, resources such as the International Skeletal Dysplasia Registry or the European Skeletal Dysplasia network should be consulted. Detailed and up-to-date information regarding the molecular tests available for the diagnosis of skeletal dysplasias is available at:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fgtr%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4tryNPgji1PaJ6Kbd%2Fo1hE9A6&amp;TOPIC_ID=14209" target="_blank">
          Genetic testing registry
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.esdn.org%2F&amp;token=aSKE78UjrroU4ioWfh%2FyefpMJ7gxcRzHid5fEzQLulU%3D&amp;TOPIC_ID=14209" target="_blank">
          European Skeletal Dysplasia Network
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.unil.ch%2F&amp;token=y%2BaffBeT3nDw7T4yvlrzcjq6ntm%2BySYppnCBGQUrqBM%3D&amp;TOPIC_ID=14209" target="_blank">
          Division of Molecular Pediatrics
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.uclahealth.org%2Fortho%2Fisdr&amp;token=jmEABjuHLhRAAGr5mhsrcawQsEHYpv5UfQKYEKXOSbdp0sj6Q2TuO3UlFkn5fIN2&amp;TOPIC_ID=14209" target="_blank">
          International Skeletal Dysplasia Registry
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fomim.org%2F&amp;token=87jLzclRwWxNoI%2BQq5Gg719fkmhU1%2BHL5BgfqtERBlQ%3D&amp;TOPIC_ID=14209" target="_blank">
          On-line Inheritance of Man
         </a>
         (OMIM)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1170149444">
         <span class="h1">
          OVERVIEW OF THE LETHAL SKELETAL DYSPLASIAS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnostic features of the hundreds of specific skeletal dysplasias is beyond the scope of this review; common skeletal dysplasia are described separately (see
         <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">
          "Skeletal dysplasias: Specific disorders"
         </a>
         ), and a comprehensive list can be found in the 2019 Nosology and Classification of Genetic Skeletal Disorders [
         <a href="#rid25">
          25,66
         </a>
         ].
        </p>
        <p>
         Lethal skeletal dysplasias are described below. When a lethal skeletal dysplasia is suspected because of severe micromelia, early onset, and/or a small chest, the more common types can be distinguished from one another by four key features: bone mineralization, fractures, macrocranium (disproportionately large head), and short trunk  (
         <a class="graphic graphic_table graphicRef50414" href="/z/d/graphic/50414.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid86">
          86
         </a>
         ]. The most important determinant of lethality is the degree of pulmonary hypoplasia.
        </p>
        <p class="headingAnchor" id="H2348325">
         <span class="h2">
          Thanatophoric dysplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Thanatophoric dysplasia (TD) is the most common lethal skeletal dysplasia, with a prevalence of 0.24 to 0.69 per 10,000 births. Some characteristic features are  (
         <a class="graphic graphic_table graphicRef50414" href="/z/d/graphic/50414.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe micromelia with rhizomelic predominance; typically, the extremities are so foreshortened that they protrude at right angles to the body
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small thoracic circumference
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macrocrania or cloverleaf skull deformity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal trunk length
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal mineralization
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         No fractures
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Thickened, redundant skin folds
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Platyspondyly (flattened vertebral bodies)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Temporal lobe dysplasia
        </p>
        <p>
        </p>
        <p>
         Type 1 (TD1) TD is the more common form of TD [
         <a href="#rid50">
          50,60,87
         </a>
         ] and is usually caused by R248C and Y373C variants in the fibroblast growth factor receptor 3 gene (
         <em>
          FGFR3
         </em>
         ). The appearance of TD1 includes the typical bowed "telephone receiver" shape of the femur [
         <a href="#rid50">
          50,60
         </a>
         ], along with frontal bossing and midface hypoplasia, but no cloverleaf skull deformity.
        </p>
        <p>
         Type 2 (TD2) TD is usually caused by the K650E variant in
         <em>
          FGFR3
         </em>
         and is less common than TD1. The femurs are typically straight with flared metaphyses. The most specific feature of TD2 is the cloverleaf skull: a trilobed appearance of the skull in the coronal plane that results from premature craniosynostosis of the lambdoid and coronal sutures.
        </p>
        <p>
         Both TD1 and TD2 are autosomal dominant conditions, with all cases caused by new dominant variants in the
         <em>
          FGFR3
         </em>
         gene. TD has many phenotypic similarities to homozygous achondroplasia, but the latter is distinguished by the positive family history [
         <a href="#rid68">
          68,86
         </a>
         ] in which both parents have achondroplasia (heterozygous for the specific
         <em>
          FGFR3
         </em>
         mutations associated with achondroplasia).
        </p>
        <p>
         Polyhydramnios is present in approximately 50 percent of affected fetuses [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p>
         TD is associated with brain abnormalities, specifically temporal lobe dysplasia (deep and transverse temporal sulci, which can be seen on brain autopsy at 18 weeks of gestation) and polymicrogyria. The abnormal deep transverse sulci in the temporal lobes can be visualized on fetal ultrasound at the time of routine second mid-trimester fetal anatomic evaluation, and thus may help in confirming the diagnosis if the patient decides not to have amniocentesis [
         <a href="#rid43">
          43,89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2348332">
         <span class="h2">
          Achondrogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Achondrogenesis is the second most common lethal skeletal dysplasia, with a prevalence of 0.09 to 0.23 per 10,000 births. Although a phenotypically and genetically diverse group of chondrodysplasias, it shares the following characteristic ultrasound features  (
         <a class="graphic graphic_table graphicRef50414" href="/z/d/graphic/50414.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid26">
          26,90-92
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe micromelia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small thoracic circumference
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Macrocrania
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Short trunk length
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased mineralization, most marked in the vertebral bodies, ischium, and pubic bones
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Occasional fractures
        </p>
        <p>
        </p>
        <p>
         Type 1 achondrogenesis (20 percent of cases) has autosomal recessive inheritance and thus has a 25 percent recurrence risk. In addition to decreased mineralization of the vertebral column, sacrum and pubic bones, type 1 achondrogenesis is also associated with calvarial demineralization. Type 1A is caused by a variant in
         <em>
          TRIP11
         </em>
         (Golgi-microtubule-associated protein, 210-kDa, GMAP210) and type 1B is associated with a variant in the
         <em>
          DTDST
         </em>
         gene (SLC26A2 sulfate transporter) [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p>
         Type 2 achondrogenesis (80 percent of cases) is an autosomal dominant condition caused by a new dominant variant in
         <em>
          COL2A1
         </em>
         , which encodes type 2 collagen and carries a low recurrence risk.
        </p>
        <p>
         Polyhydramnios is present in approximately 25 percent of affected fetuses [
         <a href="#rid88">
          88
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2348339">
         <span class="h2">
          Osteogenesis imperfecta type 2
         </span>
         <span class="headingEndMark">
          —
         </span>
         Osteogenesis imperfecta is a clinically and genetically heterogeneous group of collagen disorders characterized by brittle bones that are prone to fracture. It has been classified into four major subtypes based on genetic, radiographic, and clinical considerations, but additional, less common types also exist [
         <a href="#rid94">
          94,95
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2943.html" rel="external">
          "Osteogenesis imperfecta: An overview"
         </a>
         .)
        </p>
        <p>
         Individuals with type 2 osteogenesis imperfecta usually die in utero or in early infancy due to severe fractures and pulmonary hypoplasia  (
         <a class="graphic graphic_table graphicRef50414" href="/z/d/graphic/50414.html" rel="external">
          table 2
         </a>
         ). The key ultrasound features are [
         <a href="#rid96">
          96
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe micromelia, with femur length (FL) more than 3 standard deviations below the mean for gestational age
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small thoracic circumference
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal cranial size
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Short trunk length
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased mineralization
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiple bone fractures, including multiple fractures within a single bone and fractured ribs
        </p>
        <p>
        </p>
        <p>
         The demineralized bones have multiple angulations and thickening due to innumerable fractures and repetitive callus formation. Multiple rib fractures result in a concave thoracic contour, most evident at the lateral thorax where the elbows "bash" in the fragile rib cage  (
         <a class="graphic graphic_diagnosticimage graphicRef54731" href="/z/d/graphic/54731.html" rel="external">
          image 5
         </a>
         ). Demineralization of the cranium causes it to deform upon gentle pressure with the ultrasound transducer  (
         <a class="graphic graphic_diagnosticimage graphicRef69521" href="/z/d/graphic/69521.html" rel="external">
          image 6
         </a>
         ). Platyspondyly and micrognathia are commonly present.
        </p>
        <p>
         The diagnosis may be made sonographically as early as 13 to 15 weeks of gestational age. A normal ultrasound examination after 17 weeks essentially excludes this diagnosis.
        </p>
        <p class="headingAnchor" id="H2348346">
         <span class="h2">
          Hypophosphatasia congenita
         </span>
         <span class="headingEndMark">
          —
         </span>
         Hypophosphatasia congenita is an autosomal recessive skeletal dysplasia mapped to 1p36.1-p34 and caused by a homozygous or compound heterozygote variant in the
         <em>
          ALPL
         </em>
         gene [
         <a href="#rid97">
          97
         </a>
         ] and associated with low levels of alkaline phosphatase (see
         <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">
          "Skeletal dysplasias: Specific disorders", section on 'Hypophosphatasia'
         </a>
         ). The key ultrasound features are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe micromelia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small thoracic circumference
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal cranial size
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal trunk length
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased mineralization
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Occasional fractures
        </p>
        <p>
        </p>
        <p>
         The cranium is demineralized and compressible. The bones appear thin, delicate, or entirely absent, with occasional fractures.
        </p>
        <p class="headingAnchor" id="H2348353">
         <span class="h2">
          Campomelic dysplasia or bent-limb dysplasia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Campomelic dysplasia or bent-limb dysplasia is a rare autosomal dominant condition, usually the result of a new dominant variant in
         <em>
          SOX9
         </em>
         (sex-determining protein homeobox 9 mapped to 17q24.3); however, some of the cases are the result of a variant upstream of the
         <em>
          SOX9
         </em>
         gene [
         <a href="#rid98">
          98
         </a>
         ]. Most cases (77 percent) are lethal because of respiratory insufficiency from laryngotracheomalacia in combination with a mildly narrowed thorax. In one series, all 46 cases of campomelic dysplasia demonstrated severe hypoplasia of the scapulae, irrespective of campomelia of the femora [
         <a href="#rid48">
          48
         </a>
         ]. Similar, less severe hypoplasia of the scapulae may be present in Antley-Bixler syndrome (multisynostotic osteodysgenesis).
        </p>
        <p>
         Ultrasound features may include [
         <a href="#rid99">
          99,100
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoplastic scapula and cervical vertebrae (present in at least 63 percent of cases)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Short femur and tibia that are ventrally bowed. Bowing may also occur in the upper extremities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypoplastic or absent fibula
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Talipes equinovarus (clubfoot)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Late ossification of midthoracic pedicles
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Dislocated hips
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         11 rib pairs
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Facial abnormalities, including micrognathia and cleft palate (Robin sequence)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Congenital heart disease (present in 33 percent of cases)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Brain abnormalities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Renal abnormalities
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cutaneous skin dimpling along the ventral lower limb may be identified with surface rendered three-dimensional ultrasound
        </p>
        <p>
        </p>
        <p>
         Phenotypic sex reversal can be observed in approximately 75 percent of affected genotypic males (46, XY), with a gradation of defects ranging from ambiguous genitalia to normal female external genitalia [
         <a href="#rid101">
          101
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1750009511">
         <span class="h2">
          Skeletal ciliopathies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Defects in the biosynthesis and/or function of primary cilia cause a spectrum of disorders collectively referred to as ciliopathies [
         <a href="#rid102">
          102
         </a>
         ]
         <em>
          .
         </em>
         A subset of these disorders is associated with skeletal abnormalities that include a narrow chest with markedly short ribs, micromelia, and polydactyly. These include the perinatal lethal short-rib polydactyly syndromes (SRPS) and the less severe asphyxiating thoracic dystrophy, Ellis-van Creveld syndrome, and cranioectodermal dysplasia phenotypes.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Short-rib polydactyly syndromes
         </strong>
         – SRPS are a heterogeneous group of rare and lethal skeletal dysplasias with an autosomal recessive inheritance. They are subdivided into four groups: type 1 (Saldino-Noonan), type 2 (Majewski), type 3 (Verma-Naumoff), and type 4 (Beemer-Langer) (which can occur without polydactyly) [
         <a href="#rid97">
          97,103
         </a>
         ]. Radiographic and clinical features can distinguish them. However, there is a substantial clinical and radiological overlap between type 1 and 3 and between these and asphyxiated thoracic dystrophy [
         <a href="#rid25">
          25
         </a>
         ]. A few genes associated with this group of conditions have been identified. Type 2 is associated with variants in the genes
         <em>
          DYNC2H1
         </em>
         and
         <em>
          NEK1
         </em>
         ,
         <em>
         </em>
         and type 4 has not yet been associated with a specific gene. Thus, prenatal diagnosis using DNA analysis is possible in some of the cases.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Ultrasound features may include  (
         <a class="graphic graphic_table graphicRef50414" href="/z/d/graphic/50414.html" rel="external">
          table 2
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Severe micromelia (present in 100 percent of cases)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Small thoracic circumference (present in 100 percent of cases)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Normal cranial size
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Normal bone mineralization
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polydactyly
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Cardiac abnormalities
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Genitourinary and gastrointestinal abnormalities
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Chondroectodermal dysplasia (Ellis-van Creveld syndrome) and Jeune asphyxiating thoracic dystrophy
         </strong>
         have similar features but less severe micromelia and thoracic narrowing than the SRPS and are not associated with fetal/neonatal lethality. Chondroectodermal dysplasia is associated with postaxial polydactyly and congenital cardiac disease, typically an atrial septal defect. The condition is autosomal recessive and is caused by homozygous or compound heterozygous variants in the
         <em>
          EVC1
         </em>
         and
         <em>
          EVC2
         </em>
         genes. (See
         <a class="medical medical_review" href="/z/d/html/108252.html" rel="external">
          "Skeletal dysplasias: Specific disorders", section on 'Chondroectodermal dysplasia (Ellis-van Creveld syndrome)'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <strong>
          Jeune asphyxiating thoracic dystrophy
         </strong>
         is genetically heterogeneous autosomal recessive condition and is known to be caused by homozygous or compound heterozygous variants in the
         <em>
          DYNC2H1
         </em>
         ,
         <em>
          IFT80
         </em>
         ,
         <em>
          WDR34
         </em>
         ,
         <em>
          TTC21B
         </em>
         ,
         <em>
          WDR19 WD
         </em>
         ,
         <em>
          IFT172
         </em>
         , and
         <em>
          IFT140
         </em>
         genes. It can be associated with renal cystic disease. Variants in
         <em>
          KIAA0753
         </em>
         were found to be associated with SRPS and Joubert syndrome, thus expanding the phenotype of skeletal ciliopathy [
         <a href="#rid104">
          104
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4320.html" rel="external">
          "Chest wall diseases and restrictive physiology", section on 'Asphyxiating thoracic dystrophy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2350072">
         <span class="h2">
          Fibrochondrogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fibrochondrogenesis is a rare lethal osteochondrodysplasia with an autosomal recessive inheritance. Ultrasound features include [
         <a href="#rid105">
          105,106
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Micromelia with metaphyseal flaring (dumbbell shape)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Small thoracic circumference
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Normal cranial size
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flat facies
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Decreased mineralization of the skull
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Vertebrae display platyspondyly and midline clefts
        </p>
        <p>
        </p>
        <p>
         The short long bones have irregular metaphyses with peripheral spurs and extra-articular calcifications, giving the appearance of stippling. The condition is caused by homozygous or compound heterozygous variants in
         <em>
          COL11A1
         </em>
         and
         <em>
          COL11A2
         </em>
         .
        </p>
        <p class="headingAnchor" id="H2348376">
         <span class="h2">
          Atelosteogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atelosteogenesis is a rare lethal osteochondrodysplasia and represents a heterogeneous group of disorders. The incidence of all types of atelosteogenesis is estimated to be 1 in one million. Ultrasound features include [
         <a href="#rid107">
          107
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Severe micromelia associated with hypoplasia of the distal femur and humerus resulting in a characteristic distal long bone tapering
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bowed long bones
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Flat facies, micrognathia
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Narrow chest with short ribs
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Delayed segments of spine ossification
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hands/feet may demonstrate abducted (hitch-hiker) thumb/toe and deficient ossification of the metacarpals, proximal, and middle phalanges with preservation of distal phalangeal ossification
        </p>
        <p>
        </p>
        <p>
         Facial clefts and dislocations of the hip, knee, and elbow can occur.
        </p>
        <p>
         Atelosteogenesis type 1 and 3 have an autosomal dominant inheritance and are caused by variants in the filamin B gene and atelosteogenesis type 2 is autosomal recessive and is caused by homozygous or compound heterozygous variants in
         <em>
          DTDST
         </em>
         .
        </p>
        <p class="headingAnchor" id="H2348383">
         <span class="h2">
          Chondrodysplasia punctata or stippled epiphyses
         </span>
         <span class="headingEndMark">
          —
         </span>
         Chondrodysplasia punctata (CDP) or stippled epiphyses is etiologically a heterogeneous group of disorders with many small calcifications (ossification centers) in the cartilage, the ends of bones, and around the spine [
         <a href="#rid108">
          108,109
         </a>
         ].
        </p>
        <p>
         The rhizomelic form of CDP appears as severe, symmetrical, predominantly rhizomelic limb shortening [
         <a href="#rid97">
          97,110
         </a>
         ]. It is associated with severe intellectual disability and is generally lethal before the second year of life. The condition is the result of peroxisomal dysfunction caused by homozygous or compound heterozygous variants in
         <em>
          PEX7
         </em>
         . It can be associated with low unconjugated estriol concentration on second-trimester screening for Down syndrome. The enlarged epiphyses with characteristic stippling may be identified on ultrasound in the third trimester. The humeri tend to be relatively shorter than the femurs and have metaphyseal cupping. Other abnormalities include dysmorphic facial features, joint contractures, coronal clefting of the vertebral bodies, and brain abnormalities.
        </p>
        <p>
         Another nonrhizomelic form of CDP, the Conradi-Hünermann type, has X-linked dominant inheritance. This syndrome is usually lethal in hemizygous males. Affected females have a variable phenotype; severe prenatal ultrasonography findings are rare and include precocious asymmetric shortening and bowing of the long bones, stippled epiphysis on second-trimester ultrasound, and vertebral irregularity [
         <a href="#rid111">
          111
         </a>
         ]. The possibility of maternal autoimmune disease should be considered when the etiology of the CDP cannot be identified [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2348390">
         <span class="h2">
          Other lethal skeletal dysplasias
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other lethal skeletal dysplasias include Boomerang dysplasia, de la Chapelle dysplasia, and Schneckenbecken dysplasia. These are rare and difficult to diagnose accurately on prenatal ultrasound.
        </p>
        <p class="headingAnchor" id="H2348413">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Background
         </strong>
         – The lethal fetal skeletal dysplasias comprise a heterogeneous and complex group of conditions that affect bone growth and development. The three most common conditions detected prenatally are thanatophoric dysplasia, osteogenesis imperfecta type 2, and achondrogenesis. (See
         <a class="local">
          'Introduction'
         </a>
         above and
         <a class="local">
          'Background'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prenatal diagnosis
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Two-dimensional ultrasound is the primary imaging modality used for the initial assessment of a potentially affected fetus. (See
         <a class="local">
          'Initial ultrasound evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         When fetal skeletal dysplasia is suspected on ultrasound (eg, femur length [FL] below the fifth percentile for gestational age or 2 standard deviations below the mean for gestational age or a qualitative bone abnormality), the mother should be referred promptly to a tertiary center for specialized fetal evaluation  (
         <a class="graphic graphic_table graphicRef63933" href="/z/d/graphic/63933.html" rel="external">
          table 1
         </a>
         and
         <a class="graphic graphic_table graphicRef50414" href="/z/d/graphic/50414.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Evaluation of the fetus with a mildly shortened femur'
         </a>
         above and
         <a class="local">
          'Establishing a diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic testing
         </strong>
         – When both parents are affected with the same or different autosomal dominant skeletal disorders, the fetus is at high risk of lethality because of homozygosity or compound heterozygosity (for the same condition) or heterozygosity for two dominant conditions (double heterozygosity). In such cases, it is useful to identify the parental genetic variants before pregnancy and offer prenatal or preimplantation genetic diagnosis. (See
         <a class="local">
          'Role of molecular diagnostic testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Pregnancy management
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Predicting lethality
         </strong>
         – A primary goal following the diagnosis of fetal skeletal dysplasia is to predict lethality or the life-limiting effect. It is important to use multiple parameters to determine that the fetus has a skeletal dysplasia and to evaluate whether it is lethal/life-limiting. Secondary goals are to determine the diagnosis or to narrow the differential diagnosis. (See
         <a class="local">
          'Predicting lethality'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Counseling
         </strong>
         – Once a determination regarding the lethality and possible diagnosis is made, the couple should be counseled and given options by a team which includes perinatal imaging specialists, medical geneticists, maternal-fetal medicine specialists, and neonatologists. If both parents have skeletal dysplasia, their diagnoses should be determined and the implications of these diagnoses on their pregnancy should be discussed, including the mode of delivery and the postnatal management. (See
         <a class="local">
          'Pregnancy management'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postnatal evaluation/counseling
         </strong>
         – Following the delivery or pregnancy termination, the diagnosis should be determined/confirmed using clinical, radiographic, autopsy findings, and DNA analysis. Cell culture and DNA should be banked and used for microarray and molecular analysis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Once all of the information is gathered, the parents should be seen again to discuss the results and the implications these may have on their future reproductive plans. (See
         <a class="local">
          'Postnatal/post-termination evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Krakow D, Lachman RS, Rimoin DL. Guidelines for the prenatal diagnosis of fetal skeletal dysplasias. Genet Med 2009; 11:127.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yang J, Cummings EA, O'connell C, Jangaard K. Fetal and neonatal outcomes of diabetic pregnancies. Obstet Gynecol 2006; 108:644.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alrukban H, Chitayat D. Fetal chondrodysplasia punctata associated with maternal autoimmune diseases: a review. Appl Clin Genet 2018; 11:31.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mortier GR, Cohn DH, Cormier-Daire V, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet A 2019; 179:2393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Castilla EE, Orioli IM. Prevalence rates of microtia in South America. Int J Epidemiol 1986; 15:364.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barkova E, Mohan U, Chitayat D, et al. Fetal skeletal dysplasias in a tertiary care center: radiology, pathology, and molecular analysis of 112 cases. Clin Genet 2015; 87:330.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weldner BM, Persson PH, Ivarsson SA. Prenatal diagnosis of dwarfism by ultrasound screening. Arch Dis Child 1985; 60:1070.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rasmussen SA, Bieber FR, Benacerraf BR, et al. Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis. Am J Med Genet 1996; 61:49.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Camera G, Mastroiacovo P. Birth prevalence of skeletal dysplasias in the Italian Multicentric Monitoring System for Birth Defects. Prog Clin Biol Res 1982; 104:441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Andersen PE Jr. Prevalence of lethal osteochondrodysplasias in Denmark. Am J Med Genet 1989; 32:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Waller DK, Correa A, Vo TM, et al. The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US. Am J Med Genet A 2008; 146A:2385.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Connor JM, Connor RA, Sweet EM, et al. Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant. Am J Med Genet 1985; 22:243.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krakow D, Alanay Y, Rimoin LP, et al. Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis. Am J Med Genet A 2008; 146A:1917.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tretter AE, Saunders RC, Meyers CM, et al. Antenatal diagnosis of lethal skeletal dysplasias. Am J Med Genet 1998; 75:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Källén B, Knudsen LB, Mutchinick O, et al. Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: an international feasibility study. Int J Epidemiol 1993; 22:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schramm T, Gloning KP, Minderer S, et al. Prenatal sonographic diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol 2009; 34:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ngo C, Viot G, Aubry MC, et al. First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness. Ultrasound Obstet Gynecol 2007; 30:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Offiah AC. Skeletal Dysplasias: An Overview. Endocr Dev 2015; 28:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Orioli IM, Castilla EE, Barbosa-Neto JG. The birth prevalence rates for the skeletal dysplasias. J Med Genet 1986; 23:328.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Doray B, Favre R, Viville B, et al. Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases. Ann Genet 2000; 43:163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sharony R, Browne C, Lachman RS, Rimoin DL. Prenatal diagnosis of the skeletal dysplasias. Am J Obstet Gynecol 1993; 169:668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parilla BV, Leeth EA, Kambich MP, et al. Antenatal detection of skeletal dysplasias. J Ultrasound Med 2003; 22:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaffney G, Manning N, Boyd PA, et al. Prenatal sonographic diagnosis of skeletal dysplasias--a report of the diagnostic and prognostic accuracy in 35 cases. Prenat Diagn 1998; 18:357.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Krakow D. Skeletal dysplasias. Clin Perinatol 2015; 42:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bonafe L, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A 2015; 167A:2869.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hall CM. International nosology and classification of constitutional disorders of bone (2001). Am J Med Genet 2002; 113:65.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Olsen BR, Reginato AM, Wang W. Bone development. Annu Rev Cell Dev Biol 2000; 16:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Salomon LJ, Alfirevic Z, Da Silva Costa F, et al. ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth. Ultrasound Obstet Gynecol 2019; 53:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weisz B, David AL, Chitty L, et al. Association of isolated short femur in the mid-trimester fetus with perinatal outcome. Ultrasound Obstet Gynecol 2008; 31:512.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurtz AB, Needleman L, Wapner RJ, et al. Usefulness of a short femur in the in utero detection of skeletal dysplasias. Radiology 1990; 177:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mathiesen JM, Aksglaede L, Skibsted L, et al. Outcome of fetuses with short femur length detected at second-trimester anomaly scan: a national survey. Ultrasound Obstet Gynecol 2014; 44:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Papageorghiou AT, Fratelli N, Leslie K, et al. Outcome of fetuses with antenatally diagnosed short femur. Ultrasound Obstet Gynecol 2008; 31:507.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thame M, Osmond C, Trotman H. Fetal growth and birth size is associated with maternal anthropometry and body composition. Matern Child Nutr 2015; 11:574.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shipp TD, Bromley B, Mascola M, Benacerraf B. Variation in fetal femur length with respect to maternal race. J Ultrasound Med 2001; 20:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Speer PD, Canavan T, Simhan HN, Hill LM. Prenatal midtrimester fetal long bone measurements and the prediction of small-for-gestational-age fetuses at term. Am J Perinatol 2014; 31:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Campbell J, Henderson A, Campbell S. The fetal femur/foot length ratio: a new parameter to assess dysplastic limb reduction. Obstet Gynecol 1988; 72:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nelson DB, Dashe JS, McIntire DD, Twickler DM. Fetal skeletal dysplasias: sonographic indices associated with adverse outcomes. J Ultrasound Med 2014; 33:1085.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kumar M, Thakur S, Haldar A, Anand R. Approach to the diagnosis of skeletal dysplasias: Experience at a center with limited resources. J Clin Ultrasound 2016; 44:529.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koul R, Al-Kindy A, Mani R, et al. One in three: congenital bent bone disease and intermittent hyperthermia in three siblings with stuve-wiedemann syndrome. Sultan Qaboos Univ Med J 2013; 13:301.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padmanabha H, Suthar R, Sankhyan N, Singhi P. Stiffness, Facial Dysmorphism, and Skeletal Abnormalities: Schwartz-Jampel Syndrome 1A. J Pediatr 2018; 200:286.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rouse GA, Filly RA, Toomey F, Grube GL. Short-limb skeletal dysplasias: evaluation of the fetal spine with sonography and radiography. Radiology 1990; 174:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lefebvre M, Duffourd Y, Jouan T, et al. Autosomal recessive variations of TBX6, from congenital scoliosis to spondylocostal dysostosis. Clin Genet 2017; 91:908.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang DC, Shannon P, Toi A, et al. Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia. Ultrasound Obstet Gynecol 2014; 44:588.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pugash D, Lehman AM, Langlois S. Prenatal ultrasound and MRI findings of temporal and occipital lobe dysplasia in a twin with achondroplasia. Ultrasound Obstet Gynecol 2014; 44:365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manikkam SA, Chetcuti K, Howell KB, et al. Temporal Lobe Malformations in Achondroplasia: Expanding the Brain Imaging Phenotype Associated with FGFR3-Related Skeletal Dysplasias. AJNR Am J Neuroradiol 2018; 39:380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Hamed MH, Kurdi W, Alsahan N, et al. Renal tubular dysgenesis: antenatal ultrasound scanning and molecular investigations in a Saudi Arabian family. Clin Kidney J 2016; 9:807.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Elliott AM, Roeder ER, Witt DR, et al. Scapuloiliac dysostosis (Kosenow syndrome, pelvis-shoulder dysplasia) spectrum: three additional cases. Am J Med Genet 2000; 95:496.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mortier GR, Rimoin DL, Lachman RS. The scapula as a window to the diagnosis of skeletal dysplasias. Pediatr Radiol 1997; 27:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruano R, Molho M, Roume J, Ville Y. Prenatal diagnosis of fetal skeletal dysplasias by combining two-dimensional and three-dimensional ultrasound and intrauterine three-dimensional helical computer tomography. Ultrasound Obstet Gynecol 2004; 24:134.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CP, Chern SR, Shih JC, et al. Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia. Prenat Diagn 2001; 21:89.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Garjian KV, Pretorius DH, Budorick NE, et al. Fetal skeletal dysplasia: three-dimensional US--initial experience. Radiology 2000; 214:717.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vergani P, Andreani M, Greco M, et al. Two- or three-dimensional ultrasonography: which is the best predictor of pulmonary hypoplasia? Prenat Diagn 2010; 30:834.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gonçalves LF. Three-dimensional ultrasound of the fetus: how does it help? Pediatr Radiol 2016; 46:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arthurs OJ, Thayyil S, Addison S, et al. Diagnostic accuracy of postmortem MRI for musculoskeletal abnormalities in fetuses and children. Prenat Diagn 2014; 34:1254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cassart M, Massez A, Cos T, et al. Contribution of three-dimensional computed tomography in the assessment of fetal skeletal dysplasia. Ultrasound Obstet Gynecol 2007; 29:537.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Macé G, Sonigo P, Cormier-Daire V, et al. Three-dimensional helical computed tomography in prenatal diagnosis of fetal skeletal dysplasia. Ultrasound Obstet Gynecol 2013; 42:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wrixon AD. New ICRP recommendations. J Radiol Prot 2008; 28:161.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miyazaki O, Nishimura G, Sago H, et al. Prenatal diagnosis of fetal skeletal dysplasia with 3D CT. Pediatr Radiol 2012; 42:842.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Victoria T, Epelman M, Coleman BG, et al. Low-dose fetal CT in the prenatal evaluation of skeletal dysplasias and other severe skeletal abnormalities. AJR Am J Roentgenol 2013; 200:989.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vajo Z, Francomano CA, Wilkin DJ. The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev 2000; 21:23.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tavormina PL, Shiang R, Thompson LM, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995; 9:321.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vivanti AJ, Costa JM, Rosefort A, et al. Optimal non-invasive diagnosis of fetal achondroplasia combining ultrasonography with circulating cell-free fetal DNA analysis. Ultrasound Obstet Gynecol 2019; 53:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Geister KA, Camper SA. Advances in Skeletal Dysplasia Genetics. Annu Rev Genomics Hum Genet 2015; 16:199.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhou X, Chandler N, Deng L, et al. Prenatal diagnosis of skeletal dysplasias using a targeted skeletal gene panel. Prenat Diagn 2018; 38:692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Akolekar R, Beta J, Picciarelli G, et al. Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015; 45:16.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Warman ML, Cormier-Daire V, Hall C, et al. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A 2011; 155A:943.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Unger S, Korkko J, Krakow D, et al. Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita. Am J Med Genet 2001; 104:140.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitayat D, Fernandez B, Gardner A, et al. Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagnosis and postnatal outcome. Am J Med Genet 1999; 84:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mellis R, Oprych K, Scotchman E, et al. Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta-analysis. Prenat Diagn 2022; 42:662.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeh P, Saeed F, Paramasivam G, et al. Accuracy of prenatal diagnosis and prediction of lethality for fetal skeletal dysplasias. Prenat Diagn 2011; 31:515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nguyen JE, Salemi JL, Tanner JP, et al. Survival and healthcare utilization of infants diagnosed with lethal congenital malformations. J Perinatol 2018; 38:1674.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stembalska A, Dudarewicz L, Śmigiel R. Lethal and life-limiting skeletal dysplasias: Selected prenatal issues. Adv Clin Exp Med 2021; 30:641.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khalil A, Pajkrt E, Chitty LS. Early prenatal diagnosis of skeletal anomalies. Prenat Diagn 2011; 31:115.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hersh JH, Angle B, Pietrantoni M, et al. Predictive value of fetal ultrasonography in the diagnosis of a lethal skeletal dysplasia. South Med J 1998; 91:1137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dugoff L, Coffin CT, Hobbins JC. Sonographic measurement of the fetal rib cage perimeter to thoracic circumference ratio: application to prenatal diagnosis of skeletal dysplasias. Ultrasound Obstet Gynecol 1997; 10:269.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshimura S, Masuzaki H, Gotoh H, et al. Ultrasonographic prediction of lethal pulmonary hypoplasia: comparison of eight different ultrasonographic parameters. Am J Obstet Gynecol 1996; 175:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rypens F, Metens T, Rocourt N, et al. Fetal lung volume: estimation at MR imaging-initial results. Radiology 2001; 219:236.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williams G, Coakley FV, Qayyum A, et al. Fetal relative lung volume: quantification by using prenatal MR imaging lung volumetry. Radiology 2004; 233:457.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weaver KN, Johnson J, Kline-Fath B, et al. Predictive value of fetal lung volume in prenatally diagnosed skeletal dysplasia. Prenat Diagn 2014; 34:1326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barros CA, Rezende Gde C, Araujo Júnior E, et al. Prediction of lethal pulmonary hypoplasia by means fetal lung volume in skeletal dysplasias: a three-dimensional ultrasound assessment. J Matern Fetal Neonatal Med 2016; 29:1725.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Deshmukh S, Rubesova E, Barth R. MR assessment of normal fetal lung volumes: a literature review. AJR Am J Roentgenol 2010; 194:W212.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rubesova E. Why do we need more data on MR volumetric measurements of the fetal lung? Pediatr Radiol 2016; 46:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyers ML, Garcia JR, Blough KL, et al. Fetal Lung Volumes by MRI: Normal Weekly Values From 18 Through 38 Weeks' Gestation. AJR Am J Roentgenol 2018; 211:432.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitayat D, Babul-Hirji R. Genetic counselling in prenatally diagnosed non-chromosomal fetal abnormalities. Curr Opin Obstet Gynecol 2000; 12:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sankar VH, Phadke SR. Clinical utility of fetal autopsy and comparison with prenatal ultrasound findings. J Perinatol 2006; 26:224.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lemyre E, Azouz EM, Teebi AS, et al. Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update. Can Assoc Radiol J 1999; 50:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Langer LO Jr, Yang SS, Hall JG, et al. Thanatophoric dysplasia and cloverleaf skull. Am J Med Genet Suppl 1987; 3:167.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas RL, Hess LW, Johnson TR. Prepartum diagnosis of limb-shortening defects with associated hydramnios. Am J Perinatol 1987; 4:293.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Blaas HG, Vogt C, Eik-Nes SH. Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound. Ultrasound Obstet Gynecol 2012; 40:230.
          </a>
         </li>
         <li class="breakAll">
          Taybi H, Lachman RS. Radiology of Syndromes, Metabolic Disorders, and Skeletal Dysplasias, 3rd ed, Year Book Medical Publishers, Chicago 1990.
         </li>
         <li>
          <a class="nounderline abstract_t">
           DiMaio MS, Barth R, Koprivnikar KE, et al. First-trimester prenatal diagnosis of osteogenesis imperfecta type II by DNA analysis and sonography. Prenat Diagn 1993; 13:589.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Latini G, De Felice C, Parrini S, et al. Polyhydramnios: a predictor of severe growth impairment in achondroplasia. J Pediatr 2002; 141:274.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vanegas S, Sua LF, López-Tenorio J, et al. Achondrogenesis type 1A: clinical, histologic, molecular, and prenatal ultrasound diagnosis. Appl Clin Genet 2018; 11:69.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sillence DO, Barlow KK, Garber AP, et al. Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity. Am J Med Genet 1984; 17:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Barnes AM, Carter EM, Cabral WA, et al. Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding. N Engl J Med 2010; 362:521.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Munoz C, Filly RA, Golbus MS. Osteogenesis imperfecta type II: prenatal sonographic diagnosis. Radiology 1990; 174:181.
          </a>
         </li>
         <li class="breakAll">
          Meizner, I, Bar-Ziv, J. In utero diagnosis of skeletal disorders: an atlas of prenatal sonographic and postnatal radiologic correlation, CRC Press, Boca Raton FL 1993.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carvajal N, Martínez-García M, Chagoyen M, et al. Clinical, genetics and bioinformatics characterization of a campomelic dysplasia case report. Gene 2016; 577:289.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Irving MD, Chitty LS, Mansour S, Hall CM. Chondrodysplasia punctata: a clinical diagnostic and radiological review. Clin Dysmorphol 2008; 17:229.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mansour S, Hall CM, Pembrey ME, Young ID. A clinical and genetic study of campomelic dysplasia. J Med Genet 1995; 32:415.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Velagaleti GV, Bien-Willner GA, Northup JK, et al. Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia. Am J Hum Genet 2005; 76:652.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang W, Taylor SP, Ennis HA, et al. Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies. Hum Mutat 2018; 39:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wu MH, Kuo PL, Lin SJ. Prenatal diagnosis of recurrence of short rib-polydactyly syndrome. Am J Med Genet 1995; 55:279.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hammarsjö A, Wang Z, Vaz R, et al. Novel KIAA0753 mutations extend the phenotype of skeletal ciliopathies. Sci Rep 2017; 7:15585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Whitley CB, Langer LO Jr, Ophoven J, et al. Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathology. Am J Med Genet 1984; 19:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kulkarni ML, Matadh PS, Praveen Prabhu SP, Kulkarni PM. Fibrochondrogenesis. Indian J Pediatr 2005; 72:355.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Luewan S, Sukpan K, Udomwan P, Tongsong T. Prenatal sonographic features of fetal atelosteogenesis type 1. J Ultrasound Med 2009; 28:1091.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitayat D, Keating S, Zand DJ, et al. Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases. Am J Med Genet A 2008; 146A:3038.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Umranikar S, Glanc P, Unger S, et al. X-Linked dominant chondrodysplasia punctata: prenatal diagnosis and autopsy findings. Prenat Diagn 2006; 26:1235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Duff P, Harlass FE, Milligan DA. Prenatal diagnosis of chondrodysplasia punctata by sonography. Obstet Gynecol 1990; 76:497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lefebvre M, Dufernez F, Bruel AL, et al. Severe X-linked chondrodysplasia punctata in nine new female fetuses. Prenat Diagn 2015; 35:675.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 14209 Version 39.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19265753" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Guidelines for the prenatal diagnosis of fetal skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16946226" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Fetal and neonatal outcomes of diabetic pregnancies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29720879" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Fetal chondrodysplasia punctata associated with maternal autoimmune diseases: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31633310" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Nosology and classification of genetic skeletal disorders: 2019 revision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3771073" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Prevalence rates of microtia in South America.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24863959" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Fetal skeletal dysplasias in a tertiary care center: radiology, pathology, and molecular analysis of 112 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3907507" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Prenatal diagnosis of dwarfism by ultrasound screening.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8741918" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7163285" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Birth prevalence of skeletal dysplasias in the Italian Multicentric Monitoring System for Birth Defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2789000" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Prevalence of lethal osteochondrodysplasias in Denmark.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18698630" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3901754" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18627037" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Evaluation of prenatal-onset osteochondrodysplasias by ultrasonography: a retrospective and prospective analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9489797" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Antenatal diagnosis of lethal skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8449630" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Monitoring dominant germ cell mutations using skeletal dysplasias registered in malformation registries: an international feasibility study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19548204" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Prenatal sonographic diagnosis of skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17582228" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26138847" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Skeletal Dysplasias: An Overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3746832" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The birth prevalence rates for the skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11164199" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Prenatal sonographic diagnosis of skeletal dysplasias. A report of 47 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8372878" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Prenatal diagnosis of the skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12636325" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Antenatal detection of skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9602482" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Prenatal sonographic diagnosis of skeletal dysplasias--a report of the diagnostic and prognostic accuracy in 35 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26042906" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26394607" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Nosology and classification of genetic skeletal disorders: 2015 revision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12400068" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : International nosology and classification of constitutional disorders of bone (2001).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11031235" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Bone development.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31169958" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : ISUOG Practice Guidelines: ultrasound assessment of fetal biometry and growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18432603" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Association of isolated short femur in the mid-trimester fetus with perinatal outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2399317" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Usefulness of a short femur in the in utero detection of skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24357398" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Outcome of fetuses with short femur length detected at second-trimester anomaly scan: a national survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18286672" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Outcome of fetuses with antenatally diagnosed short femur.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23241104" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Fetal growth and birth size is associated with maternal anthropometry and body composition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11211134" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Variation in fetal femur length with respect to maternal race.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23690053" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Prenatal midtrimester fetal long bone measurements and the prediction of small-for-gestational-age fetuses at term.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3292975" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The fetal femur/foot length ratio: a new parameter to assess dysplastic limb reduction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24866616" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Fetal skeletal dysplasias: sonographic indices associated with adverse outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27218215" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Approach to the diagnosis of skeletal dysplasias: Experience at a center with limited resources.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23862038" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : One in three: congenital bent bone disease and intermittent hyperthermia in three siblings with stuve-wiedemann syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29866592" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Stiffness, Facial Dysmorphism, and Skeletal Abnormalities: Schwartz-Jampel Syndrome 1A.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2403680" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Short-limb skeletal dysplasias: evaluation of the fetal spine with sonography and radiography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27861764" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Autosomal recessive variations of TBX6, from congenital scoliosis to spondylocostal dysostosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24585534" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Temporal lobe dysplasia: a characteristic sonographic finding in thanatophoric dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24616001" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Prenatal ultrasound and MRI findings of temporal and occipital lobe dysplasia in a twin with achondroplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29170271" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Temporal Lobe Malformations in Achondroplasia: Expanding the Brain Imaging Phenotype Associated with FGFR3-Related Skeletal Dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27994858" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Renal tubular dysgenesis: antenatal ultrasound scanning and molecular investigations in a Saudi Arabian family.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11146473" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Scapuloiliac dysostosis (Kosenow syndrome, pelvis-shoulder dysplasia) spectrum: three additional cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9133361" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The scapula as a window to the diagnosis of skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15287049" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Prenatal diagnosis of fetal skeletal dysplasias by combining two-dimensional and three-dimensional ultrasound and intrauterine three-dimensional helical computer tomography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11241532" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Prenatal diagnosis and genetic analysis of type I and type II thanatophoric dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10715036" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Fetal skeletal dysplasia: three-dimensional US--initial experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20582919" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Two- or three-dimensional ultrasonography: which is the best predictor of pulmonary hypoplasia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26829949" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Three-dimensional ultrasound of the fetus: how does it help?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25043483" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Diagnostic accuracy of postmortem MRI for musculoskeletal abnormalities in fetuses and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17444568" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Contribution of three-dimensional computed tomography in the assessment of fetal skeletal dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22945478" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Three-dimensional helical computed tomography in prenatal diagnosis of fetal skeletal dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18495983" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : New ICRP recommendations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22532233" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Prenatal diagnosis of fetal skeletal dysplasia with 3D CT.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23617480" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Low-dose fetal CT in the prenatal evaluation of skeletal dysplasias and other severe skeletal abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10696568" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7773297" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29380944" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Optimal non-invasive diagnosis of fetal achondroplasia combining ultrasonography with circulating cell-free fetal DNA analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25939055" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Advances in Skeletal Dysplasia Genetics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29907962" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Prenatal diagnosis of skeletal dysplasias using a targeted skeletal gene panel.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25042845" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Procedure-related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21438135" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Nosology and classification of genetic skeletal disorders: 2010 revision.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11746045" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Double heterozygosity for pseudoachondroplasia and spondyloepiphyseal dysplasia congenita.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10360393" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Compound heterozygosity for the Achondroplasia-hypochondroplasia FGFR3 mutations: prenatal diagnosis and postnatal outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35170059" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: A systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21370244" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Accuracy of prenatal diagnosis and prediction of lethality for fetal skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30237475" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Survival and healthcare utilization of infants diagnosed with lethal congenital malformations.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34019743" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Lethal and life-limiting skeletal dysplasias: Selected prenatal issues.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21210484" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Early prenatal diagnosis of skeletal anomalies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9853726" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Predictive value of fetal ultrasonography in the diagnosis of a lethal skeletal dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9383879" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Sonographic measurement of the fetal rib cage perimeter to thoracic circumference ratio: application to prenatal diagnosis of skeletal dysplasias.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8765272" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Ultrasonographic prediction of lethal pulmonary hypoplasia: comparison of eight different ultrasonographic parameters.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11274563" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Fetal lung volume: estimation at MR imaging-initial results.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15459321" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Fetal relative lung volume: quantification by using prenatal MR imaging lung volumetry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25102973" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Predictive value of fetal lung volume in prenatally diagnosed skeletal dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26135769" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Prediction of lethal pulmonary hypoplasia by means fetal lung volume in skeletal dysplasias: a three-dimensional ultrasound assessment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20093576" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : MR assessment of normal fetal lung volumes: a literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26829947" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Why do we need more data on MR volumetric measurements of the fetal lung?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29894217" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Fetal Lung Volumes by MRI: Normal Weekly Values From 18 Through 38 Weeks' Gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10813567" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Genetic counselling in prenatally diagnosed non-chromosomal fetal abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16541112" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Clinical utility of fetal autopsy and comparison with prenatal ultrasound findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10405653" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Bone dysplasia series. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: review and update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3130852" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Thanatophoric dysplasia and cloverleaf skull.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3307798" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Prepartum diagnosis of limb-shortening defects with associated hydramnios.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22374812" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22374812" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Abnormal gyration of the temporal lobe and megalencephaly are typical features of thanatophoric dysplasia and can be visualized prenatally by ultrasound.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8415424" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : First-trimester prenatal diagnosis of osteogenesis imperfecta type II by DNA analysis and sonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12183727" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Polyhydramnios: a predictor of severe growth impairment in achondroplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29872333" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Achondrogenesis type 1A: clinical, histologic, molecular, and prenatal ultrasound diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6702894" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Osteogenesis imperfecta type II delineation of the phenotype with reference to genetic heterogeneity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20089953" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2403681" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Osteogenesis imperfecta type II: prenatal sonographic diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2403681" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Osteogenesis imperfecta type II: prenatal sonographic diagnosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26631621" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Clinical, genetics and bioinformatics characterization of a campomelic dysplasia case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18978650" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Chondrodysplasia punctata: a clinical diagnostic and radiological review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7666392" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : A clinical and genetic study of campomelic dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15726498" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Position effects due to chromosome breakpoints that map approximately 900 Kb upstream and approximately 1.3 Mb downstream of SOX9 in two patients with campomelic dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29068549" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Expanding the genetic architecture and phenotypic spectrum in the skeletal ciliopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7726223" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Prenatal diagnosis of recurrence of short rib-polydactyly syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29138412" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Novel KIAA0753 mutations extend the phenotype of skeletal ciliopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6507478" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Fibrochondrogenesis: lethal, autosomal recessive chondrodysplasia with distinctive cartilage histopathology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15876767" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Fibrochondrogenesis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19643794" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Prenatal sonographic features of fetal atelosteogenesis type 1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19006208" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Chondrodysplasia punctata associated with maternal autoimmune diseases: expanding the spectrum from systemic lupus erythematosus (SLE) to mixed connective tissue disease (MCTD) and scleroderma report of eight cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17086568" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : X-Linked dominant chondrodysplasia punctata: prenatal diagnosis and autopsy findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2199870" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Prenatal diagnosis of chondrodysplasia punctata by sonography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25754886" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Severe X-linked chondrodysplasia punctata in nine new female fetuses.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
